Janice A Blalock, Ph.D.
Department of Behavioral Science, Division of Cancer Prevention and Population Sciences
About Dr. Blalock
Janice A. Blalock, Ph.D. is a clinical psychologist with 23 years research experience in treatments for depression and anxiety disorders, and nicotine dependence. Her research area of interest is the development of smoking cessation treatments for smokers with comorbid psychiatric and medical disorders. She has served as a Co-P.I. or PI on a number of NIH grants evaluating smoking cessation interventions in smokers with comorbid psychiatric and health conditions including pregnant women, chronically depressed smokers and cancer patients. She is currently conducting a NIH-funded treatment development study to evaluate Behavioral Activation as depression-focused intervention for pregnant women with major depression. She has published numerous articles evaluating the impact of clinical depression and childhood trauma on withdrawal and abstinence outcomes among smokers with current depressive disorders, and the effect of psychiatric disorders on abstinence outcomes in cancer patients.
Present Title & Affiliation
Primary Appointment
Professor, Department of Behavioral Science, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1992 | Virginia Polytechnic Institute & State University, Blacksburg, Virginia, US, Clinical Psychology, Ph.D |
| 1991 | Medical University of South Carolina, Charleston, South Carolina, US, Internship, Psychology, Training |
| 1987 | University of the Pacific, Stockton, California, US, Psychology, MA |
| 1980 | Southwest Texas State University, San Marcos, Texas, US, Psychology, BS |
Experience & Service
Academic Appointments
Associate Professor, Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2022
Assistant Professor, Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - 2007
Instructor, Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - 2000
Assistant Professor, Department of Clinical Track, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical Branch, Galveston, TX, 1991 - 1999
Administrative Appointments/Responsibilities
Assistant Director, Department of Tobacco Treatment Program, The University of Texas MD Anderson Cancer Center, Houston, 2005 - 2017
Co-Director, Mood and Anxiety Disorders Program, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical Branch, Galveston, 1991 - 1996
Other Appointments/Responsibilities
Co-Chair, Advisory Committee, Society for Research on Nicotine & Tobacco Treatment Network, Houston, TX, 2019 - 2021
Member, Advisory Committee, Society for Research on Nicotine & Tobacco Treatment Network, Houston, TX, 2017 - 2018
Chair, Society for Research on Nicotine & Tobacco Treatment Network Education Subcommittee, Madison, WI, 2013 - 2017
Institutional Committee Activities
Chair, Irene Tami-Maury Mid-Career Review Committee, 2019
Member, INTEREST Review Committee, 2019 - Present
Member, Mexican American Cohort Study Internal Steering Committee, 2018 - 2018
Member, Behavioral Science Faculty Mentoring Program Work Group, 2018 - 2020
Chair, Department of Behavioral Science Psycho-oncology Faculty Search Committee, 2017 - 2019
Member, Credentials Committee of the Medical Staff, 2016 - 2018
Lead, CFA and RFA Revisions to Career Trajectory Protocol, 2016 - 2016
Director, Clinical Psychology, Clinical Health Education Profession Committee, 2016 - Present
Member, Faculty Senate, 2015 - 2021
Member, MD Anderson Psychologist Committee, 2015 - 2019
Member, Epic Routine for Mental Health Providers, 2014 - 2015
Member, Postdoctoral Advisory Committee, MD Anderson Cancer Center, 2014 - 2016
Member, Jennifer Minnix Mid-Tenure Review Committee, 2014
Member, Remuneration/Compensation Ad Hoc Committee, 2013 - 2015
Member, Clinical Care Workgroup, 2013 - 2015
Member, Distress Algorithm Workgroup, 2013 - 2014
Member, LeMaistre Lectureship Committee, 2012 - 2013
Member, Mid Career Development Program Planning Committee Women Faculty Programs, 2012 - 2013
Member, Early Career Development Program Planning Committee, Women Faculty Programs, 2011 - 2012
Chair, Jason Robinson Mid-Career Review Committee, 2011
Chair, Michelle Fingeret Mid-Tenure Review Committee, 2010
Member, Institutional Research Grant-Clinical Study Section, 2010 - 2013
Member, Smoking Abatement Committee, 2006
Member, Cancer Prevention Research Training Program Advisory Committee, 2005 - Present
Member, Practitioner Peer Assistance Committee, 2005 - Present
Chair, Department of Behavioral Science Mental Health Emergency Procedures Committee, 2005
Member, Psychosocial, Behavioral, and Health Services Research Committee, 2004 - 2007
Member, Division of Cancer Prevention Seminar Speaker Selection Committee, 2003 - 2004
Member, Faculty Health and Well Being Committee, 2002 - 2012
Member, Junior Faculty Committee Department of Behavioral Science, 2000 - Present
Chair, Behavioral Science Departmental Seminar Committee, 2000 - 2014
Honors & Awards
| 2020 | Leading Mentor in Cancer Prevention |
| 2011 | Faculty Educator of the Month, The University of Texas MD Anderson Cancer Center |
| 2011 | Honorable Mention, Mentor, Division of Cancer Prevention, The University of Texas MD Anderson Cancer Center |
| 2010 | AAMC Mid-Career Women Faculty Professional Development Seminar |
| 2008 | Nominee for Leading Mentor in Cancer Prevention Award, The University of Texas MD Anderson Cancer Center |
| 1985 | Achievement Rewards for College Scientists Scholarship, College Scientists Scholarship Northern California chapter |
| 1981 | Cited for Academic Excellence, Southwest Texas State University School of Education |
| 1981 | Cited for Excellence in English, Southwest Texas State Department of English |
| 1981 | Cited for Research, Southwest Texas State University School of Education |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Manning, K, Zvolensky, MJ, Gallagher, MW, Alfano, C, Viana, AG, Blalock, J. Understanding Fatigue Severity and Smoking Deprivation in Smoking Behavior and Urges. Experimental and clinical psychopharmacology 33(3):285-290, 2025. e-Pub 2025. PMID: 40048234.
- Manning K, Zvolensky MJ, Gallagher MW, Alfano C, Viana AG, Blalock JA. Understanding Fatigue Severity and Smoking Deprivation in Smoking Behavior and Urges: A Pilot Test. Exp Clin Psychopharmacol. e-Pub 2025.
- Kypriotakis G, Cinciripini PM, Green C, Lawrence D, Anthenelli RM, Minnix JA, Beneventi D, Morris C, Karam-Hage M, Blalock JA. The Effects of Varenicline, Bupropion, Nicotine Patch and Placebo on Treating Smoking among Persons with Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial. The American Journal of Psychiatry, 2024. e-Pub 2024.
- Cinciripini PM, Kypriotakis G, Blalock JA, Karam-Hage M, Beneventi DM, Robinson JD, Minnix JA, Warren GW. Improved Survival Using Early Intervention with Smoking Cessation After a Cancer Diagnosis. JAMA Oncology, 2024. e-Pub 2024.
- Cinciripini PM, Green CE, Shete S, Minnix JA, Robinson JD, Cui Y, Kim S, Kypriotakis G, Beneventi D, Blalock JA, Versace F, Karam-Hage M. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial. JAMA 331(20):1722-1731, 2024. e-Pub 2024. PMID: 38696203.
- Rodríguez-Cano R, Kypriotakis G, Robinson JD, Karam-Hage M, Blalock JA, Minnix JA, Beneventi D, Cinciripini PM. Comparing the Fagerström Test and Heaviness of Smoking Index in Predicting Smoking Abstinence in Cancer Patients. Nicotine Tob Res. e-Pub 2024. PMID: 38785358.
- Kypriotakis G, Kim S, Karam-Hage M, Robinson JD, Minnix JA, Blalock JA, Cui Y, Beneventi D, Kim B, Pan IW, Shih YT, Cinciripini PM. Examining the Association between Abstinence from Smoking and Healthcare Costs Among Patients with Cancer. Cancer Prev Res (Phila) 17(5):217-225, 2024. e-Pub 2024. PMID: 37940143.
- Robinson JD, Kypriotakis G, Karam-Hage M, Cui Y, Beneventi D, Blalock JA, Minnix JA, Cinciripini PM. Brief report: Characterization of electronic cigarette use among patients of a comprehensive cancer center. Am J Addict 33(3):339-342, 2024. e-Pub 2024. PMID: 37807121.
- Correa-Fernandez, V, Tavakoli, N, Motsenbocker, M, Kim, H, Wetter, DW, Blalock, J, Canino, G, Piper, ME. Culturally relevant acceptance-based telehealth wellness program for Latine adults who smoke and experience psychological distress. Journal of Contextual Behavioral Science 32, 2024. e-Pub 2024.
- Cinciripini PM, Minnix JA, Robinson JD, Kypriotakis G, Cui Y, Blalock JA, Lam CY, Wetter DW. The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance. JMIR Form Res 7:e39487, 2023. e-Pub 2023. PMID: 37338956.
- Correa-Fernández V, Blalock JA, Piper ME, Canino G, Wetter DW. Acceptance and Commitment Therapy Wellness Program for Latine Adults Who Smoke and Have Psychological Distress: Protocol for a Feasibility Study. JMIR Res Protoc 12:e44146, 2023. e-Pub 2023. PMID: 37014678.
- Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict 31(3):236-241, 2022. e-Pub 2022. PMID: 35347796.
- Kypriotakis G, Cinciripini PM, Green C, Lawrence D, Anthenelli RM, Minnix J, Beneventi D, Morris C, Karam-Hage M, Blalock JA. The Effects of Varenicline, Bupropion, Nicotine Patch and Placebo on Smoking Cessation among Smokers with Major Depression: A Randomized Clinical Trial. Depress Anxiety 39(5):1-12, 2022. e-Pub 2022. PMID: 35535436.
- Salloum RG, Rojewski AM, Piper ME, Blalock JA, Borrelli B, Boyce LM, Minnix JA, Dogar O, Tomko RL, Jorenby DE, Kotsen C, Ostroff JS. Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations. Nicotine Tob Res 24(2):150-159, 2022. e-Pub 2022. PMID: 34197617.
- Rodriguez-Cano R, Paulus DJ, Derrick JL, Blalock JA, Zvolensky MJ. Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers. J Subst Abuse Treat 132:108508, 2022. e-Pub 2022. PMID: 34098209.
- Cancer Center Cessation Initiative Implementation Science Working Group: Schnoll R, Chen L, Ramsey AT, Presant CA, Jose T, Ashing KT, Shelley D, Bernstein SL, Fleisher L, Salloum RG, Warren GW, Wiseman KP, Blalock JA, Dahl NA, Farka EB, Manders D, Ostroff JS, Park ER, Adsit R, Hohl SD, Minion M, Pauk D, Rolland B. Implementation science to improve tobacco cessation services in oncology care. J Natl Compr Canc Netw 19(Suppl_1):S12-S15, 2021. e-Pub 2021. PMID: 34872048.
- Cox-Martin E, Cox MG, Basen-Engquist K, Bradley C, Blalock JA. Changing multiple health behaviors in cancer survivors: smoking and exercise. Psychol Health Med 25(3):1-13, 2020. e-Pub 2020. PMID: 31630537.
- Tamí-Maury I, Sharma A, Chen M, Blalock JA, Ortiz J, Weaver L, Shete S. Comparing smoking behavior between female-to-male and male-to-female transgender adults. Tob Prev Cessat 6:2, 2020. e-Pub 2020. PMID: 32548339.
- Cinciripini PM, Karam-Hage M, Kypriotakis G, Robinson JD, Rabius V, Beneventi D, Minnix JA, Blalock JA. Association of a comprehensive smoking cessation program with smoking abstinence among patients with cancer. JAMA Netw Open 2(9):e1912251, 2019. e-Pub 2019. PMID: 31560387.
- Minnix JA, Blalock JA, Karam-Hage M, Cinciripini PM. The importance of incorporating smoking cessation into lung cancer screening. Translational Lung Cancer Research 7(3):272-280, 2018. e-Pub 2018. PMID: 30050765.
- Karam-Hage M, Kypriotakis G, Robinson JD, Green CE, Mann G, Rabius V, Wippold R, Blalock JA, Mouhayer E, Tayar J, Chaftari P, Cinciripini PM. Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis. Journal of Clinical Psychopharmacology 38(1):34-41, 2018. e-Pub 2018. PMID: 29232312.
- Cofta-Woerpel L, Lam C, Reitzel L, Wilson W, Karam-Hage M, Beneventi D, Cofer J, Baker E, WetterD, Cinciripini P, Blalock JA. A tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers. Cogent Medicine:5: 1430652, 2018. e-Pub 2018. PMID: 30364535.
- Cox M, Basen-Engquist K, Carmack CL, Blalock JA, Li Y, Murray J, Pisters L, Rodriguez-Bigas M, Song J, Cox-Martin E, Demark-Wahnefried W. Comparison of internet and telephone interventions for weight loss among cancer survivors: Randomized controlled trial and feasibility study. JMIR Cancer 3(2):e16, 2017. e-Pub 2017. PMID: 28954716.
- Karam-Hage M, Oughli HA, Rabius V, Beneventi D, Wippold RC, Blalock JA, Cinciripini PM. Tobacco cessation treatment pathways for patients with cancer: 10 years in the making. J Natl Compr Canc Netw 14(11):1469-1477, 2016. e-Pub 2016. PMID: 27799514.
- Farris SG, Robinson JD, Zvolensky MJ, Hogan J, Rabius V, Cinciripini PM, Karam-Hage M, Blalock JA. Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment. Addict Behav 61:32-9, 2016. e-Pub 2016. PMID: 27235990.
- Martin EC, Basen-Engquist K, Cox MG, Lyons EJ, Carmack CL, Blalock JA, Demark-Wahnefried W. Interest in health behavior intervention delivery modalities among cancer survivors: A cross-sectional study. JMIR Cancer 2(1/e1):e1, 2016. e-Pub 2016. PMID: 28410164.
- Bluethmann SM, Basen-Engquist K, Vernon SW, Cox M, Gabriel KP, Stansberry SA, Carmack CL, Blalock JA, Demark-Wahnefried W. Grasping the 'teachable moment': time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors. Psychooncology 24(10):1250-1257, 2015. e-Pub 2015. PMID: 26060053.
- Parrott CE, Rathnayaka N, Blalock JA, Minnix JA, Cinciripini PM, Vincent JP, Wetter DW, Green C. Examination of the Wisconsin inventory of smoking dependence motives (WISDM-68) factor structure in a sample of pregnant smokers. Nicotine Tob Res 17(6):653-60, 2015. e-Pub 2015. PMID: 25475086.
- Wippold R, Karam-Hage M, Blalock JA, Cinciripini P. Selection of optimal tobacco cessation medication treatment in patients with cancer. Clin J Oncol Nurs 19(2):170-5, 2015. e-Pub 2015. PMID: 25840382.
- Stotts AL, Northrup TF, Cinciripini PM, Minnix JA, Blalock JA, Mullen PD, Pedroza C, Blackwell S. Randomized, controlled pilot trial of bupropion for pregnant smokers: Challenges and future directions. Am J Perinatol 32(4):351-6, 2015. e-Pub 2015. PMID: 25111040.
- Lin J, Blalock JA, Chen M, Ye Y, Gu J, Cohen L, Cinciripini PM, Wu X. Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiol Biomarkers Prev 24(2):336-43, 2015. e-Pub 2015. PMID: 25416716.
- Farris SG, Zvolensky MJ, Blalock JA, Schmidt NB. Negative affect and smoking motives sequentially mediate the effect of panic attacks on tobacco-relevant processes. Am J Drug Alcohol Abuse 40(3):230-239, 2014. e-Pub 2014. PMID: 24720260.
- Mathew AR, Robinson JD, Norton PJ, Cinciripini PM, Brown RA, Blalock JA. Affective trajectories before and after a quit attempt in smokers with current depressive disorders. Nicotine Tob Res 15(11):1807-1815, 2013. e-Pub 2013. PMID: 23509093.
- Blalock JA, Minnix JA, Mathew AR, Wetter DW, McCullough JP, Cinciripini PM. Relationship of childhood trauma to depression and smoking outcomes in pregnant smokers. J Consult Clin Psychol 81(5):821-30, 2013. e-Pub 2013. PMID: 23750463.
- Blalock JA, Nayak N, Wetter DW, Schreindorfer L, Minnix JA, Canul J, Cinciripini PM. The relationship of childhood trauma to nicotine dependence in pregnant smokers. Psychol Addict Behav 25(4):652-63, 2011. e-Pub 2011. PMID: 21928869.
- Minnix JA, Blalock JA, Marani S, Prokhorov AV, Cinciripini PM. Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Nicotine Tob Res 13(8):699-705, 2011. e-Pub 2011. PMID: 21482619.
- Blalock JA, Lam, CY, Minnix, JA, Karam-Hage, M, Gritz, ER, Robinson, JD, Cinciripini, PM. The effect of mood, anxiety and alcohol use disorders on smoking cessation in cancer patients. Journal of Cognitive Psychotherapy 25(1):82-96, 2011. e-Pub 2011.
- Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, Wetter DW, Schreindorfer L, McCullough JP, Dolan-Mullen P, Stotts AL, Karam-Hage M. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. J Consult Clin Psychol 78(1):44-54, 2010. e-Pub 2010. PMID: 20099949.
- Clague J, Cinciripini P, Blalock JA, Wu X, Hudmon KS. The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behav Genet 40(1):49-58, 2010. e-Pub 2010. PMID: 19842028.
- Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, Wetter DW, Garden AS, Sturgis EM, Cinciripini PM. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer 115(19):4336-4344, 2009. e-Pub 2009. PMID: 19569250.
- Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, Manber R, Blalock JA, Keitner GI, Thase ME. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord 117(3):174-9, 2009. e-Pub 2009. PMID: 19217168.
- Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychol Addict Behav 22(1):122-128, 2008. e-Pub 2008. PMID: 18298238.
- Blalock JA, Fouladi RT, Cinciripini PM, Markowitz JC, Klein DN, Rothbaum BO, Arnow BA, Manber R, Riso LP, Sui D, McCullough JP, Jr. Cognitive and behavioral mediators of combined pharmacotherapy and psychotherapy of chronic depression. Cognitive Therapy and Research 32:197-211, 2008. e-Pub 2008.
- Blalock JA, Robinson JD, Wetter DW, Cinciripini PM. Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. Am J Addict 15(4):268-77, 2006. e-Pub 2006. PMID: 16867921.
- Mallen MJ, Blalock JA, Cinciripini PM. Using technology to serve patients and practitioners: a comprehensive tobacco-cessation program for cancer patients. Counseling and Psychotherapy Research 6(3):196-201, 2006. e-Pub 2006.
- Blalock JA, Fouladi RT, Wetter DW, Cinciripini PM. Depression in pregnant women seeking smoking cessation treatment. Addict Behav 30(6):1195-208, 2005. e-Pub 2005. PMID: 15925128.
- Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry 62(5):513-20, 2005. e-Pub 2005. PMID: 15867104.
- Santiago NJ, Klein DN, Vivian D, Arnow BA, Blalock JA, Kocsis JH, Markowitz JC, Manber R, Riso LP, Rothbaum BO, Rush AJ, Thase ME, McCullough, Jr JP, Keller MB. The therapeutic alliance and CBASP-specific skill acquisition in the treatment of chronic depression. Cognitive Therapy and Research 29(6):803-817, 2005. e-Pub 2005.
- Klein DN, Santiago NJ, Vivian D, Blalock JA, Kocsis JH, Markowitz JC, McCullough JP, Rush AJ, Trivedi MH, Arnow BA, Dunner DL, Manber R, Rothbaum B, Thase ME, Keitner GI, Miller IW, Keller MB. Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. J Consult Clin Psychol 72(4):681-8, 2004. e-Pub 2004. PMID: 15301653.
- Vocisano C, Klein DN, Arnow BA, Rivera C, Blalock JA, Rothbaum B, Vivian D, Markowitz JC, Kocsis JH, Manber R, Castonguay L, Rush AJ, Borian FF, McCullough JP, Kornstein SG, Riso LP, Thase ME. Therapist variables that predict symptom change in psychotherapy with chronically depressed outpatients. Psychotherapy: Theory, Research, Practice, Training 41:255-265, 2004. e-Pub 2004.
- Klein DN, Schwartz JE, Santiago NJ, Vivian D, Vocisano C, Castonguay LG, Arnow B, Blalock JA, Manber R, Markowitz JC, Riso LP, Rothbaum B, McCullough JP, Thase ME, Borian FE, Miller IW, Keller MB. Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. J Consult Clin Psychol 71(6):997-1006, 2003. e-Pub 2003. PMID: 14622075.
- Arnow BA, Manber R, Blasey C, Klein DN, Blalock JA, Markowitz JC, Rothbaum BO, Rush AJ, Thase ME, Riso LP, Vivian D, McCullough JP, Keller MB. Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. J Consult Clin Psychol 71(6):1025-35, 2003. e-Pub 2003. PMID: 14622078.
- Manber R, Arnow B, Blasey C, Vivian D, McCullough JP, Blalock JA, Klein DN, Markowitz JC, Riso LP, Rothbaum B, Rush AJ, Thase ME, Keller MB. Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. Psychol Med 33(4):693-702, 2003. e-Pub 2003. PMID: 12785471.
- Cinciripini PM, Wetter DW, Fouladi RT, Blalock JA, Carter BL, Cinciripini LG, Baile WF. The effects of depressed mood on smoking cessation: mediation by post cessation self-efficacy. J Consult Clin Psychol 71(2):292-301, 2003. e-Pub 2003. PMID: 12699023.
- Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J Other authors: Blalock JA. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342(20):1462-1470, 2000. e-Pub 2000. PMID: 10816183.
- Cinciripini PM, McClure JB, Wetter DW, Perry J, Blalock JA, Cinciripini LG, Friedman KE, Skaar K. An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the very important pregnant smokers (VIPS) program. Tob Control 9 Suppl 3:III61-3, 2000. e-Pub 2000. PMID: 10982910.
- Blalock JA, Joiner TE, Jr. Interaction of cognitive avoidance coping and stress in predicting depression and anxiety: Gender differences. Cognitive Therapy and Research 24:47-65, 2000. e-Pub 2000.
- Joiner TE, Blalock JA, Wagner KD. Preliminary examination of sex differences in depressive symptoms among adolescent psychiatric inpatients: the role of anxious symptoms and generalized negative affect. J Clin Child Psychol 28(2):211-9, 1999. e-Pub 1999. PMID: 10353080.
- Metalsky GI, Jr JT, Wonderlich SA, Beatty WW, Stanton RD, Blalock JA. When will bulimics be depressed and when not? The moderating role of attributional style. Cognitive Therapy and Research 21:61-72, 1997. e-Pub 1997.
- Joiner TE, Jr, Catanzaro, S, Laurant J, Sandkin B, Blalock JA. Review of a model of depression, anxiety and negative emotion. Revistia de Psicopatologia y Psicologia Clinica 1:27-34, 1996. e-Pub 1996.
- Joyner TE Jr, Blalock JA. Gender differences in depression: the role of anxiety and generalized negative affect. Sex Roles 33:91-108, 1995. e-Pub 1995.
- Eisler RM, Blalock JA. Masculine gender role stress: implications for assessment and treatment of men. Clinical Psychology Review 11:45-60, 1991. e-Pub 1991.
- Miller SM, Blalock JA, Ginsburg HJ. Children and the aged: attitudes, contact, and discriminative ability. International Journal of Aging and Human Development 19:47-53, 1984. e-Pub 1984. PMID: 6519815.
Manuals, Teaching Aids, Other Teaching Publications
- Glenwater AM, Blalock J, Goepfert, H, Cinciripini P. Rehabilitation and quality of life, 2000.
Editorials
- Rabius V, Karam-Hage M, Blalock JA, Cinciripini PM. "Meaningful use" provides a meaningful opportunity. Cancer 120(4):464-468, 2014. PMID: 24496865.
Abstracts
- Javaid M, Cofer J, Garcia S, Blalock J, Karam-Hage M. Linking Training and Continuous Education: Developing a Comprehensive Approach to Tobacco Treatment Training. NCTOH, 2025.
- Javaid M, Garcia S, Cofer J, Blalock J, Karam-Hage M. Developing a Shared Community of Practice for Treating Tobacco Use Disorder. Society for Research on Nicotine and Tobacco, 2025.
- Nguyen C, Karam-Hage M, Kypriotakis G, Robinson J, Minnix J, Beneventi D, Blalock J, Cinciripini P. Impact of Panic Disorder on Smoking Cessation Among Cancer Patients in a Tobacco Treatment Program. Society for Research on Nicotine & Tobacco, 2025.
- Lyons E, Basen-Engquist K, Blalock JA, Demark-Wahnefried W. Preferences of breast cancer survivors for traditional and new media delivery of health promotion interventions. Journal of Women’s Health 22(10):893-893, 2013. e-Pub 2013.
- Basen-Engquist K, Carmack C, Blalock JA, Baum G, Rahming D, Demark-Wahnefried W. Predictors of cancer survivors' receptivity to lifestyle behavior change interventions. Cancer Epidemiology, Biomarkers, and Prevention 21(3):559-560, 2012. e-Pub 2012.
- Miller LA, Karam-Hage MA, Lal LS, Mallen M, Feng C, Blalock J, Cinciripini P. Economic evaluation of a tobacco cessation program at a major cancer center. Value of Health 11(6):A468-A468, 2008. e-Pub 2008.
- Russell JM, Crown WH, Arnow BA, Blalock JA, Dunner DL, Hirschfeld RMA, Kocsis JH, Koran LM, Kornstein SG, Manber R, Markowitz JC, Rush AF, Thase ME, Trivedi MH, Berndt E, Finkelstein SN, Borian FE. Economic aspects of nefazadone, CBASP, and their combination for the treatment of chronic depression. European Neuropsychopharmacology 10:239-239, 2000. e-Pub 2000.
- Skidmore JR, Eisler RM, Blalock JA, Sikkema KI. Cardiovascular reactivity in men as a function of masculine gender role stress. Biofeedback and Self-Regulation 13(1):94, 1988. e-Pub 1988.
- Hannon R, Blalock J, Risi S, Bene C, Robisch C, Day CL. Computer-based cognitive rehabilitation with brain injured young adults. Archives of Clinical Neuropsychology 1(3):271-271, 1986. e-Pub 1986.
Book Chapters
- Cofta-Woerpel, L, Lam C, Reitzel LR, Wilson W, Karam-Hage M, Beneventi D, Cofer J, Baker E, Wetter DW, Cinciripini PM, Blalock J. A Tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers. In: Prime Archives in Medicine. 2nd Edition. Vide Leaf Hyderabad, 2020.
- Coyne JC, Jr JT, Blalock JA. On the interpersonal nature of depression: Overview and synthesis. In: Interactional nature of depression: Advances in interpersonal approaches. American Psychological Association, 3-19, 1999.
Selected Presentations & Talks
Local Presentations
- 2019. Smoking cessation processes in cancer patients. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Using a neuroaffective biomarker to match smokers to treatment. Gulf Coast Consortium Addiction Conference. Houston, TX, US.
- 2018. Real-Time Audio/Video Comparable to In-Person Treatment for Smoking. Gulf Coast Consortia Addiction Cluster Meeting. Houston, TX, US.
- 2018. Treatment of Smoking in Special Populations. UT MD Anderson Cancer Center. Houston, TX, US.
- 2017. Smoking cessation treatment in primary care and oncology practice settings. Oral Oncology Symposium. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2016. Project TEACH: Disseminating a Tele-mentoring Tobacco Cessation Case Consultation and Provider Education Model to Community Mental Health Centers in Texas. MD Anderson Cancer Center. Houston, TX, US.
- 2016. Role of anxiety in smoking cessation in cancer patients: A pilot study. University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Main outcome findings from a pilot study evaluating a depression-focused smoking cessation intervention for smokers with current chronic depressive disorders. Rice University. Houston, TX, US.
- 2015. Treatment of Smokers with Co-Morbid Psychiatric Disorders. University of Houston. Houston, TX, US.
- 2014. Tobacco Use and Special Populations: Mental Health Disparities. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2014. Smoking cessation treatment in head and neck cancer patients. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Treatment of smokers with comorbid psychiatric disorders. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Treatment of smokers with comorbid psychiatric disorders. University of Houston. Houston, TX, US.
- 2012. Changes in affect following smoking cessation in depressed smokers. State of MDACC Cancer Survivorship Research. Houston, TX, US.
- 2012. Optimizing the delivery of lifestyle interventions in cancer survivor populations. UT MD Anderson Cancer Center. Houston, TX, US.
- 2008. The grip of tobacco: The science, cessation and future strategies. U.T. MD Anderson Cancer Center. Houston, TX, US.
- 2006. Smoking cessation treatments: Clinical practice guideline and recently developed medications. Academy of Family Physicians. Houston, TX, US.
- 2004. Smoking cessation treatments: Clinical practice guideline. Texas Academy of Family Physicians. Houston, TX, US.
- 2003. Lung cancer prevention. Kelsey Research Foundation. Houston, TX, US.
- 2001. Smoking cessation, Panel I: Fighting cancer through prevention, early detection, new therapies and research. Wheeler Avenue Baptist Church Cancer Ministry. Houston, TX, US.
- 1992. Treating panic disorder: An integrated approach, Workshop. Anxiety Disorders Association of America. Houston, TX, US.
Regional Presentations
- 2022. Impact of treating Insomnia symptoms on abstinence from smoking. 2022 SRNT Annual Meeting. Baltimore, MD, US.
- 2019. An Overview of Tobacco Prevention and Control Activities. Eliminate Tobacco Use. Austin, TX, US.
- 2016. Intervention with pregnant women and smoking cessation. Texas Public Health Coalition. Austin, TX, US.
- 2015. A Multi-Layered Smoking Cessation Program for Cancer Patients: First Year Outcomes. CPRIT Innovations in Cancer Prevention and Research Conference. Austin, TX, US.
- 2011. MD Anderson Cancer Center Tobacco Treatment Program: Effective smoking cessation assistance for cancer patients. CPRIT. Austin, TX, US.
- 2007. Smoking Cessation: New approaches to an old problem. American Health Resources Inc. Corpus Christi, TX, US.
- 2003. How to talk to your patients about smoking cessation: Clinical Practice Guideline. University of Texas M. D. Anderson Cancer Center. Richmond, TX, US.
- 1997. Psychotherapy and depression. Gulf Coast Alliance for the Mentally Ill Convention. League City, TX, US.
- 1995. Meta-analytic review of variables affecting psychotherapy outcome. University of Texas Medical Branch. Galveston, TX, US.
- 1995. Cognitive therapy for depression. Annual Titus Harris Meeting. San Antonio, TX, US.
- 1994. Relative efficacy of different psychotherapies for depressive disorders. University of Texas Medical Branch. Galveston, TX, US.
- 1994. Feminine gender role and the sex difference in depression. University of Texas Medical Branch. Galveston, TX, US.
- 1994. A cognitive model of panic disorder. Panic Disorder: Awareness, Recognition, and Treatment. Lake Jackson, TX, US.
- 1992. Outpatient clinical research: Mood and Anxiety Disorders Program (with Bernstein R). Texas Society of Psychiatric Physicians Annual Meeting and Scientific Program. Dallas, TX, US.
- 1992. Grand Rounds, Cognitive behavioral treatment of obsessive compulsive disorder. University of Texas Medical Branch. Galveston, TX, US.
National Presentations
- 2025. Linking Training and Continuous Education: Developing a Comprehensive Approach to Tobacco Treatment Training. 2025 National Conference on Tobacco or Health. Chicago, Illinois, US.
- 2023. The Relationships of Childhood Trauma and Post-Traumatic Stress Disorder to Smoking Outcomes in Cancer Patients. Society for Research on Nicotine & Tobacco. San Antonio, TX, US.
- 2023. The Association Of Substance Use Disorder And Ability To Quit Smoking Among Cancer Patients. SRNT 2023 29th Annual Meeting. San Antonio, TX, US.
- 2022. Cognitive and behavioral mediators of treatment for chronic depression. In: R. Manber's (Chair) Predictors and mode-specific factors in the treatment of depression. Symposium. Reno, NV, US.
- 2022. Association Between Quitting Smoking and Survival in Cancer Patients. SRNT 28th Annual Meeting. Baltimore, MD, US.
- 2022. Impact of Treating Insomnia Symptoms on Abstinence from Smoking - Poster. Society for Research on Nicotine and Tobacco. Baltimore, MD, US.
- 2021. Treatment Fidelity in Behavioral Tobacco Cessation Trials – Scoping Review and Measurement Recommendations. Society For Research on Nicotine and Tobacco Annual Meeting. Virtual, US.
- 2020. The interaction of alcohol and smoking rate in relation to cigarette dependence, perceived barriers for quitting, and expectancies for smoking among Spanish-speaking Latinx smokers. The 2nd International Conference on Advancing the Science of Cancer in Latinos. San Antonio, TX, US.
- 2019. The Effect of Baseline Insomnia and its Treatment on the Ability to Quit Smoking - Poster. American Academy of Addiction Psychiatry. San Diego, CA, US.
- 2019. Connecting the Dots: Two Complementary Approaches to Enhance and Sustain Tobacco Treatment Practices within Health Systems. Poster. Minneapolis, MN, US.
- 2019. The effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on cessation among smokers with Current and Past Major Depression. Paper presentation. San Francisco, CA, US.
- 2019. Evaluating the impact of Insomnia on the ability to quit smoking. Poster. San Francisco, CA, US.
- 2019. Using a neuroaffective biomarker to match smokers to either varenicline or nicotine patch treatment. Poster presentation. San Francisco, CA, US.
- 2018. Real-Time Audio/Video Versus In-Person Treatment for Smoking. American Academy of Addiction Psychiatry. Bonita Springs, FL, US.
- 2018. The impact of major depressive disorder and depressive symptoms on the ability to quit smoking: A Case Control Cohort. International Society for Affective Disorders Conference 2018. Houston, TX, US.
- 2018. Treatment and Research Issues in Smokers with Physical Comorbidity in Secondary Outpatient Care: Cancer and Lung Cancer Screening. Society for Research on Nicotine and Tobacco. Baltimore, MD, US.
- 2017. Understanding the longitudinal relationship between self-efficacy for physical activity and self-efficacy for smoking cessation in cancer survivors. 41st Annual Meeting of the American Society of Preventive Oncology. Seattle, WA, US.
- 2017. Determinants of multiple health behavior change in cancer survivors who smoke. Society of Behavioral Medicine 38th Annual Meeting and Scientific Sessions. San Diego, CA, US.
- 2016. Disseminating a Tele-mentoring Tobacco Cessation Case Consultation and Provider Education Model to Community Mental Health Centers in Texas. American Public Health Association 2016 Annual Meeting & Expo. Denver, CO, US.
- 2016. The Impact of Creating a Multi-Layered Smoking Cessation Program for Cancer Patients on Reach, Utilization, and Cessation. 2016 SRNT 22nd Annual Meeting. Chicago, IL, US.
- 2015. Varenicline and Combined NRT for Initial Smoking Cessation and Rescue Treatment in Smokers: A Randomized Pilot Trial. Cancer Prevention and Research Institute of Texas Annual Conference. Austini, TX, US.
- 2015. Main outcome findings from a pilot study evaluating a depression-focused smoking cessation intervention for smokers with current chronic depressive disorders. Rice University. Houston, TX, US.
- 2015. Predictors of health behavior information delivery preference in cancer survivors. Poster Presentation. 36th Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine. San Antonio, TX, US.
- 2015. A multi-layered smoking cessation program for cancer patients: first year outcomes. Poster Presentation. 21st Annual Meeting Society for Research on Nicotine and Tobacco, SRNT. Philadelphia, PA, US.
- 2014. Panic Attacks indirectly effect nicotine dependence and smoking-related processes through negative affect and negative affect reduction motives. 2014 Annual Convention of the Anxiety and Depression Association of America. Chicago, IL, US.
- 2014. Bupropion-XL has the same effectiveness and similar side effect profile as bupropion-SR when used for smoking cessation among cancer patients. 2014 Society for Research on Nicotine & Tobacco. Seattle, WA, US.
- 2014. Main outcome findings from a pilot study evaluating a depression-focused smoking cessation intervention for smokers with current chronic depressive disorders. Society for Research on Nicotine & Tobacco 20th Annual Meeting. Seattle, WA, US.
- 2014. Challenges in recruitment for a phase II trial of bupropion for smoking cessation in pregnancy. 2014 Annual Society for Research on Nicotine and Tobacco. Seattle, WA, US.
- 2014. Development and effectiveness of a multi-layered tobacco cessation program for cancer patients. 2014 Society for Research on Nicotine and Tobacco. Seattle, WA, US.
- 2013. Use of electronic health records increases referrals to the Tobacco Treatment Program at MD Anderson Cancer Center. Society for Research on Nicotine & Tobacco 19th Annual International Meeting. Boston, MA, US.
- 2013. Findings from a pilot study to evaluate a depression-focused intervention for smokers with current chronic depression. In V. Correa-Fernandez (chair) Mediators of the association of depression with smoking cessation. Symposium Collaborative Perspectives on Addiction. Symposium. Atlanta, GA, US.
- 2012. Predictors of health behaviors among breast, colorectal, and prostate cancer survivors. Summer Student Research Exposition. Houston, TX, US.
- 2012. Is cancer diagnosis a teachable moment for health behavior change. Biennial Cancer Survivorship Research Conference. Arlington, VA, US.
- 2012. Assessing tobacco use and providing tobacco cessation to cancer patients. American Association for Cancer Research's Annual Meeting 2012. Chicago, IL, US.
- 2012. Predictors of cancer survivors' receptivity to lifestyle behavior change interventions. American Society of Preventive Oncology. Washington, DC, US.
- 2012. Evaluation of mediators of an intensive depression-focused intervention for pregnant smokers using mediated moderation analysis. Society for Research on Nicotine and Tobacco. Houston, TX, US.
- 2012. Affective trajectories before and after a Quit attempt in smoker with current depressive disorders. Society for Research on Nicotine and Tobacco 2012 Annual Meeting. Houston, TX, US.
- 2012. Smoking cessation as a function of physical and psychiatric comorbidities. Society for Research on Nicotine and Tobacco 18th Annual Meeting. Houston, TX, US.
- 2010. Smoking cessation intervention in head and neck cancer patients. AHNS 2010 Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer. Washington, DC, US.
- 2010. Effect of an intensive, depression-focused smoking cessation intervention on nicotine withdrawal in women with and without current major depression. SRNT 2010 Annual Meeting. Baltimore, MD, US.
- 2009. Clinical models of care delivery: M. D. Anderson Cancer Center, Tobacco Treatment Program. Treating Tobacco Dependence Meeting. Bethesda, MD, US.
- 2008. Prevalence of psychiatric disorders in cancer patients receiving tobacco-cessation treatment. SRNT, Society for Research on Nicotine and Tobacco. Portland, OR, US.
- 2008. A comprehensive tobacco-cessation treatment for cancer patients: preliminary outcome findings. SRNT, Society for Research on Nicotine and Tobacco. Portland, OR, US.
- 2008. Smoking and recurrent disease in a head and neck cancer population receiving radiotherapy. SRNT 14th Annual Meeting. Portland, OR, US.
- 2008. Does combining bupropion-SR and varenicline make a difference? A preliminary efficacy report in cancer patients. SRNT 14th Annual Meeting. Portland, OR, US.
- 2007. Demographic & psychiatric characteristics of pregnant smokers: implications for smoking cessation treatment. March of Dimes 2007 Perinatal Conference. Spokane, WA, US.
- 2007. Development of a clinical treatment pathways for a unique tobacco cessation program within a comprehensive cancer center. Oncology Nursing Society 2007 APN Conference. Chicago, IL, US.
- 2007. Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Society for Research on Nicotine and Tobacco. Austin, TX, US.
- 2006. Treatment of tobacco dependence in head and neck cancer patients: M.D. Anderson Cancer Center Tobacco Treatment Program. The American Head & Neck Society. Chicago, IL, US.
- 2006. Comprehensive tobacco-cessation treatment for cancer patients: The challenge of implementing the clinical practice guideline. Society for Research on Nicotine and Tobacco. Orlando, FL, US.
- 2006. Does scheduled reduced smoking have a place among smoking cessation treatments. Society for Research on Nicotine and Tobacco. Orlando, FL, US.
- 2001. Transdermal nicotine and gradual reduction for smoking cessation. Society for Research on Nicotine and Tobacco Meeting. Seattle, WA, US.
- 2000. Treatment of chronic depression: Cognitive Behavioral Analysis System of Psychotherapy (CBASP), Institute. New Orleans, LA, US.
- 2000. Design, sample description and demographic findings of study comparing the efficacy of nefazodone, cognitive behavioral analysis system of psychotherapy for chronic depression (CBASP), and their combination for chronic depression In: B.A. Arnow's (Chair) Results of the largest trial yet conducted comparing medication, psychotherapy, and combined treatment for chronic depression. Symposium. Association for the Advancement of Behavior Therapy. New Orleans, LA, US.
- 2000. Novel approaches to combination treatment. 11th World Conference on Tobacco OR Health. Chicago, IL, US.
- 2000. Study Design. In: B. A. Arnow's (Chair), Comparison of medication, psychotherapy and combination treatment for chronic depression. Washington, DC, US.
- 2000. Examining prevalence of depression among pregnant smokers currently enrolled in a smoking cessation program. Society for Research on Nicotine and Tobacco. Washington, DC, US.
- 1998. Cognitive behavioral therapy for chronic depression. Association for the Advancement of Behavior Therapy. Washington, DC, US.
- 1997. Assessment of patient's interpersonal style and development of the therapeutic role. In J. McCullough's (Chair), Cognitive behavior therapy for chronic. Association for the Advancement of Behavior Therapy. Miami, FL, US.
- 1997. CBT-CD and interpersonal issues. In: J. McCullough's (Chair), Cognitive behavior therapy for chronic depression: Clinical procedures and interpersonal issues. Symposium. Chicago, IL, US.
- 1995. The stability of personality disorder following treatment of social phobia symptoms. Anxiety Disorders Association of America. Pittsburgh, PA, US.
- 1992. Outpatient clinical research: Mood and Anxiety Disorders Program. Texas Society of Psychiatric Physicians Annual Meeting and Scientific Program. Dallas, TX, US.
- 1992. Treating panic disorder: An integrated approach. Anxiety Disorders Association of America. Houston, TX, US.
- 1990. The relationship between masculine gender role stress and emotional inexpressiveness. In R.M. Eisler (Chair), Masculine gender role stress: Implications for men's health. Association for Advancement of Behavior Therapy. San Francisco, CA, US.
- 1990. Masculine gender role stress appraisal: Emotional expressiveness and psychophysiological reactivity. Boston, MA, US.
- 1988. Cardiovascular reactivity in men as a function of masculine gender role stress. Biofeedback Society of America. Colorado Springs, CO, US.
- 1986. Computer-based cognitive rehabilitation with brain-injured young adults. Seattle, WA, US.
- 1986. The effects of health-related feedback on a smoking cessation. In R.C. Katz (Chair), Smoking prevention. Symposium. San Mateo, CA, US.
- 1985. A comparison of two approaches to software. Tutorial presentation. D.W. Matheson (Chair), A training task for psychology: Improving microcomputer hardware and software documentation. Los Angeles, CA, US.
- 1985. Electromyography scanning: Implications for its use in the diagnosis of tension and migraine headache. San Jose, CA, US.
- 1981. The lag effect in prose. Houston, Texas, US.
- 1981. Children's understanding of and attitudes toward aging. Houston, TX, US.
International Presentations
- 2024. The Effects of Smoking Cessation on Overall Survival Among Patients with and without Cancer. Society for Research on Nicotine & Tobacco (SRNT). Edinburgh, GB.
- 2023. Cancer survivors’ access to technology and attitudes towards eHealth and mHealth Interventions. Medicine 2.0. London, US.
- 2023. The Effect of Anxiety Disorders on Smoking Cessation in Cancer Patients. E-SRNT. London, GB.
- 2013. Moderation of CBASP treatment effect by childhood trauma in depressed pregnant smokers. Cognitive Behavioral Analysis System of Psychotherapy. Marburg, DE.
- 2012. Depression and short telomere length increased mortality in bladder cancer patients. Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention Research. Anaheim, US.
- 2011. Effectiveness of smoking cessation assistance for cancer patients. Society for Research on Nicotine and Tobacco Research. Toronto, CA.
- 2011. Changes in affect following smoking cessation in depressed smokers. Association for Behavioral and Cognitive Therapies. Toronto, CA.
- 2009. Nicotine withdrawal in chronically depressed smokers undergoing intensive smoking cessation treatment. NIDA, IN.
- 2008. Economic evaluation of a tobacco cessation program at a major cancer center. ISPOR 11th Annual European Congress. Athens, GR.
- 1999. Understanding the primitive psychopathology of chronically depressed adults. In: J. McCullough's (Chair), Treatment of chronic depression: Cognitive Behavioral Analysis System of Psychotherapy (CBASP). Workshop. Association for Advancement of Behavior Therapy. Toronto, CA.
- 1999. Design of study comparing the efficacy of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and their combination for chronic depression. In: J. McCullough's (Chair), A controlled multicenter investigation comparing the efficacy of Nefazodone, psychotherapy, and their combination for chronic depression: Acute phase results. Symposium. Toronto, CA.
Formal Peers
- 2014. Treatment of smokers with comorbid psychiatric disorders. Invited. Houston, TX, US.
- 2010. Smoking cessation in oncology patient and survivor populations: An imperative, and a model program. Invited. Buffalo, NY, US.
- 2008. Smoking cessation treatment in primary care and oncology practice settings. Invited. Fort Worth, TX, US.
- 2004. Evaluating a mood management intervention for pregnant smokers. Invited. Galveston, TX, US.
Grant & Contract Support
| Date: | 2024 - 2029 |
| Title: | Supporting Tobacco-Related Ongoing Education and Research (STRONGER) Scholar Program |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 1R25DA059907-01 |
| Date: | 2024 - 2029 |
| Title: | Preventing Tobacco-Related Cancers by Expanding Capacity for Tobacco Use Interventions Within Agencies Serving Women with Behavioral Health Needs |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | PP240005 |
| Date: | 2023 - 2025 |
| Title: | Tobacco Research and Treatment Training Program |
| Funding Source: | MD Anderson Permanent Health Funds |
| Role: | Co-PI |
| ID: | N/A |
| Date: | 2021 - 2022 |
| Title: | Cancer Prevention Education: Student Research Experiences |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 5R25CA056452-29 |
| Date: | 2021 - 2023 |
| Title: | The JUSTICE Project: Achieving Social Justice and Equity in Flavored Combustible Tobacco Product Use Among Communities of Color |
| Funding Source: | UTH-MDA Population Health Initiative Collaborative Projects Fund |
| Role: | Co-PI |
| Date: | 2020 - 2024 |
| Title: | Pilot study to evaluate a behavioral activation prenatal and postpartum intervention for depressed pregnant smokers |
| Funding Source: | NIH/NIDA |
| Role: | PI |
| ID: | 1R34DA048265-01A1 |
| Date: | 2020 - 2022 |
| Title: | CCSG supplement: DCPPS Expanding the reach of University of Texas MD Anderson Cancer Center Tobacco Treatment Program |
| Funding Source: | NIH/NCI |
| Role: | Program Leader |
| ID: | 3 P30 CA016672-44S6 |
| Date: | 2019 - 2024 |
| Title: | Expanding Tobacco Cessation in Northeast Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | PP190009 |
| Date: | 2018 - 2024 |
| Title: | Gender differences in Standard Research E-Cigarette (SREC) product use, acceptability, reinforcement, and nicotine dependence symptoms |
| Funding Source: | NIH/NIDA |
| Role: | Co-I |
| ID: | U01DA047875 |
| Date: | 2018 - 2024 |
| Title: | Increasing access to smoking cessation and smoke free home services for low-income pregnant women in northeast Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | PP180077 |
| Date: | 2016 - 2019 |
| Title: | Optimizing Effectiveness of Smoking Cessation Invention During LDCT screening for Lung Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA207078 |
| Date: | 2016 - 2018 |
| Title: | ENDependence |
| Funding Source: | Arnold Foundation |
| Role: | Co-I |
| Date: | 2015 - 2018 |
| Title: | Varenicline and combined NRT for initial smoking cessation and rescue treatment in smokers. A randomized pilot trial |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP150228 |
| Date: | 2013 - 2016 |
| Title: | Innovative tobacco cessation intervention for oncology patients in Puerto Rico |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| ID: | 5U54CA096300 |
| Date: | 2009 - 2012 |
| Title: | Enhanced tobacco cessation program for university students |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA069425 |
| Date: | 2009 - 2011 |
| Title: | Preliminary Effectiveness and Safety of Bupropion to Promote Smoking Cessation During Pregnancy |
| Funding Source: | The Center for Clinical and Translational Sciences (CCTS) |
| Role: | Co-I |
| ID: | CCTS T2 MRP |
| Date: | 2009 - 2013 |
| Title: | Intensive Smoking Cessation Intervention for Head and Neck Cancer Patients |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | R01CA120153 |
| Date: | 2009 - 2012 |
| Title: | Optimizing the delivery of lifestyle interventions in cancer survivors |
| Funding Source: | MDACC-MRP |
| Role: | Project 3 Leader: Concurrent vs. sequential smoking and physical activity intervention for cancer survivors |
| Date: | 2008 - 2011 |
| Title: | Administrative supplement to: Smoking cessation intervention for depressed smokers: Treatment development; entitled relationship of emotional reactivity to abstinence outcomes in smokers with current chronic depressive disorders |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3R01MH076776-03S1 |
| Date: | 2006 - 2011 |
| Title: | Smoking cessation intervention for depressed smokers: Treatment development |
| Funding Source: | NIMH |
| Role: | PI |
| ID: | 5 R01 MH076776-03 |
| Date: | 2003 - 2009 |
| Title: | A mood management intervention for pregnant smokers |
| Funding Source: | NIDA |
| Role: | Co-PI |
| ID: | 5 R01 DA014301 |
| Date: | 2002 - 2004 |
| Title: | Developmental Project to 1 P50 CA91846: A study to evaluate the combination of scheduled smoking and Bupropion SR versus Bupropion SR alone for smoking cessation in bladder cancer patients |
| Funding Source: | NCI |
| Role: | PI |
| Date: | 2001 - 2003 |
| Title: | A pilot study to evaluate a mood management smoking cessation intervention in depressed smokers |
| Funding Source: | The University of Texas M.D. Anderson Cancer Center |
| Role: | PI |
| ID: | Institutional Research Grant |
| Date: | 1998 - 2004 |
| Title: | Scheduled smoking with transdermal nicotine |
| Funding Source: | NIDA |
| Role: | Co-I |
| ID: | 1 R01 DA11822-04 |
| Date: | 1997 - 2002 |
| Title: | Study 1: The relationship between a potential genetic marker (DRD2A1 Allele) of nicotine abuse liability to psychological and pharmacological measures of nicotine dependence. Study 2: Genetics, mood, and nicotine withdrawal |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | P50 CA70907 |
Patient Reviews
CV information above last modified June 18, 2025